首页> 外国专利> METHOD PREDICTING CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER p53

METHOD PREDICTING CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER p53

机译:基于凋亡标记p53的UVEA黑色素瘤临床过程预测方法

摘要

FIELD: medicine, ophthalmology, in particular. SUBSTANCE: method is realized by means of immunohistochemical analysis of cells of removed tumor, percentage of cells expressing p53 with relation to total number of tumor cells in field of vision is established. If their number exceeds 20% and more probability of progressing metastasis is predicted in 65% of cases. EFFECT: increased accuracy and objectivity of prediction of clinical course of uvea melanoma. 3 dwg
机译:领域:医学,尤其是眼科。物质:通过免疫组织化学方法对切除的肿瘤细胞进行分析,确定了视野中表达p53的细胞相对于肿瘤细胞总数的百分比。如果它们的数量超过20%,则在65%的病例中预计转移的可能性更高。效果:增加葡萄膜黑色素瘤临床病程预测的准确性和客观性。 3 dwg

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号